SanMelix Laboratories, Inc. (“SanMelix”) was formed to commercially develop bioactive wound dressings and compositions that have shown remarkable efficacy in the treatment of a variety of wound and dermal afflictions.

​

Dr. Sabacinski co-invented our patented BEECure™ M product which demonstrated superior clinical outcomes.  Our products have higher standardization and broader spectrum anti-microbial activity allowing them to be used by physicians in the fight against anti-microbial resistance pathogens.